Maroeska Rovers, Professor of Evidence Based Surgery, will receive a Vici research grant of 1.5 million euros from NWO (Netherlands Organisation for Scientific Research).Over the next five years, the researchers can use this money to perform their research and build their own research groups. The Vici grant is one of the largest individual scientific prizes in the Netherlands. This year, the NWO awarded 35 Vici grants in total.
Maroeska Rovers is Professor of Evidence-based Surgery at Radboud university medical center, within the theme of Urological cancers. It is her ambition to contribute to the development of effective, affordable, and valuable surgical innovations.
Rovers will use her Vici grant to perform research with the aim of developing better methods to evaluate surgical innovations as early as possible. Currently, this evaluation takes place when these innovations have largely been developed and marketed. Up to half of the innovations do not add any value which results in a waste of healthcare costs in Europe. According to Rovers, new medical tools should already be evaluated for added value for patients as early as the very first concept. She intends to develop, test, and validate methods for this.
Related news items
The PRIDE Study Evaluation of online methods of data collection16 January 2020
In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.read more
Laparoscopy reduces the number of adhesions but it is still too high14 January 2020
Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues.read more
Radboud Talks 2020 scientific pitch competition14 January 2020
The next edition of Radboud Talks will take place in the spring. During this academic pitch competition, young researchers will be given the opportunity to share their stories with a large audience. In a three-minute presentation, you will talk about your research in a fun and accessible manner.read more
Review Sanne Frambach accepted by Pharmacological Reviews13 January 2020
In this review entitled 'Brothers in arms: ABCA1 and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment', RIMLS researcher Sanne Frambach, describe the possibilities for stimulating cellular efflux.read more
Prostate cancer can now be diagnosed better using artificial intelligence9 January 2020
RIHS researchers Wouter Bulten and Geert Litjens have developed a ‘deep learning’ system that is better than most pathologists at determining the aggressiveness of prostate cancer. The Artificial Intelligence system taught itself to identify prostate cancer based on data from over 1200 patients.read more